# Bioequivalence Study Between YHP1906 Tab. 5 mg and YHR1902 Tab. 5 mg

> **NCT04316065** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 30 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** YHP1906
- **DRUG:** YHR1902

## Key facts

- **NCT ID:** NCT04316065
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-11
- **Primary completion:** 2020-04-20
- **Final completion:** 2020-04-24
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04316065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04316065, "Bioequivalence Study Between YHP1906 Tab. 5 mg and YHR1902 Tab. 5 mg". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04316065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*